MedPath

RESPIRICS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30â„¢ DPI

Phase 1
Completed
Conditions
Allergic Asthma
Interventions
First Posted Date
2007-11-30
Last Posted Date
2008-02-15
Lead Sponsor
Respirics Inc.
Target Recruit Count
12
Registration Number
NCT00565591
Locations
🇺🇸

Iowa Clinical Research Corporation, Iowa City, Iowa, United States

© Copyright 2025. All Rights Reserved by MedPath